Higher Therapeutics initiates real-world research for digital therapeutic for diabetes


At home ” Better Therapeutics initiates a real study on digital therapy for diabetes

Better Therapeutics announced today that it has started a real-world evidence study evaluating its treatment for type 2 diabetes.

In collaboration with Steward Health Care, Better Therapeutics is evaluating BT-001, an experimental, prescription digital therapeutic (PDT) intended to offer patients with uncontrolled type 2 diabetes a novel form of cognitive behavioral therapy. This emerges from a press release.

You can find the full story on our sister site Drug Delivery Business News.

Reader interactions